Third Arc Bio
Cassandra Lowenstein is a seasoned professional in the biopharmaceutical industry, currently serving as Senior Associate Director and Head of Discovery Labs at Third Arc Bio since March 2024. Previously, Cassandra held the position of Principal Scientist at Proteovant Therapeutics from March 2022 to March 2024, and spent over 13 years at The Janssen Pharmaceutical Companies of Johnson & Johnson in various roles including Senior Scientist, where responsibilities included advancing therapeutic targets in ImmunoOncology and driving pre-clinical drug discovery efforts. Cassandra began their career in research at Thomas Jefferson University as a Researcher/Adjunct Professor supporting bioassay development. Educational qualifications include a Master of Science and a Bachelor of Science in Biotechnology from Jefferson Health, complemented by a Bachelor of Science in Biology from Mansfield University of Pennsylvania.
This person is not in any teams
Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.